Featured Research

from universities, journals, and other organizations

First Blood Test To Diagnose Paralyzing, Blinding Disease

Date:
December 22, 2004
Source:
Mayo Clinic
Summary:
Misdiagnosis of a severely paralyzing disease can now be averted due to a blood test developed by Mayo Clinic researchers and their Japanese collaborators. Often misdiagnosed as multiple sclerosis, neuromyelitis optica (NMO) also causes blindness in many sufferers.

(Graphic courtesy of Mayo Clinic)

ROCHESTER, Minn. -- Misdiagnosis of a severely paralyzing disease can now be averted due to a blood test developed by Mayo Clinic researchers and their Japanese collaborators. Often misdiagnosed as multiple sclerosis, neuromyelitis optica (NMO) also causes blindness in many sufferers. The findings of this international collaborative effort appear in the current issue of The Lancet (http://www.lancet.org).

The finding will help doctors correctly treat NMO -- also known as Devic's syndrome -- sooner and more effectively. In some countries, misdiagnosis may be as high as 30 percent. Early diagnosis is important because NMO is best treated differently than multiple sclerosis. Treatment requires immune suppressive medications in the first instance, rather than the immune modulatory treatments typically prescribed for MS. Therefore, a patient who has NMO, but is misdiagnosed with MS, may not receive optimal care at the earliest possible time.

NMO affects the optic nerves and spinal cord -- and within five years causes half of affected patients to lose vision in at least one eye. Many lose the ability to walk independently. The prognosis for loss of sight and permanent paralysis is much worse for patients who have NMO than for those who have MS. MS is not confined to optic nerve and spinal cord involvement. However, the symptoms of the two diseases overlap, and optic nerve and spinal cord involvement occur in both. NMO is particularly difficult to distinguish from MS in the early phases of the disease.

"Early diagnosis and treatment are of paramount importance to reduce the severity of the course of NMO," says Vanda A. Lennon, M.D., Ph.D., Mayo Clinic neuroimmunologist who led the international research team. In addition to colleagues at Mayo Clinic locations in Rochester, Minn., and Scottsdale, Ariz., the team is composed of scientists from Tohoku University School of Medicine in Sendai, Japan. "With this biomarker, physicians are in a much better position to start optimal therapies sooner, and hopefully, lessen the impact of the disease," Dr. Lennon says. "This is really a very exciting development."

About NMO

Neuromyelitis optica is a debilitating inflammatory disease that destroys the protective myelin sheath around the optic nerve and spinal cord. This ultimately leads to impaired vision -- including blindness -- impaired mobility and loss of bladder and bowel control. Its cause is unknown, and prognosis is generally poor -- though early diagnosis can help. If diagnosed correctly before the myelin sheath is too damaged, plasma exchange therapy and immunosuppressive medications such as azathioprine and corticosteroids can be effective in stopping the damage and restoring nerve function.

It's not clear how many people have NMO, though it's generally regarded as rare in the United States. However, one Mayo Clinic physician in Rochester has seen approximately 50 cases in the last three years, and an equal number of variants of NMO, such as recurrent transverse myelitis and recurrent optic neuritis. Ninety percent are women aged 30-60.

By some estimates, one of four African Americans diagnosed with MS may actually have NMO instead. NMO is considerably more common in Japan and Asia, where its prevalence is about three per 100,000 citizens. In Japan, roughly one-third of patients diagnosed with MS-like illness may actually have NMO.

Without the new blood test, classic NMO can only be distinguished from MS by the extensive spinal cord lesions it inflicts spanning three or more segments of the bony spine, and by lack of MS-type lesions found by magnetic resonance imaging of the brain.

About the Investigation

Blood samples were taken from patients in the United States and Japan and evaluated for the presence of a newly identified central-nervous system autoantibody. All antibodies are circulating proteins produced by the immune system. Unlike antibodies of healthy persons which attack invading disease organisms, an autoantibody attacks normal body constituents by a poorly understood error in immune function. This new autoantibody (named NMO-IgG) was discovered in the Mayo Clinic Neuroimmunology Laboratory in the course of analyzing 85,000 blood samples. However, the significance of the antibody was not initially appreciated. Based on a study of one group of patients with clinically recognized NMO, the researchers discovered that this "unclassified" antibody was common among these patients and therefore useful as a diagnostic biomarker for NMO.

The results show that 73 percent of a group of North American patients with NMO had the biomarker. Of 22 patients with similar symptoms, but who ultimately were shown to have MS rather than NMO, only two (9 percent) had tested positive for NMO-IgG. Statistically, this means the new test is sufficiently powerful to discriminate between patients who present with similar symptoms, but whose subsequent disease course shows that they have different disorders, MS or NMO. It is the first diagnostic tool ever to do this. Results were similar among the Japanese patients studied.

In addition to Dr. Lennon, the Mayo Clinic research team included Thomas Kryzer, Claudia Lucchinetti, M.D., Sean Pittock, M.D., Dean Wingerchuk, M.D., and Brian Weinshenker, M.D. Collaborators from Tohoku University School of Medicine included Kazuo Fujihara, M.D., and Ichiro Nakashima, M.D. Their work was supported by the Mayo Foundation.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "First Blood Test To Diagnose Paralyzing, Blinding Disease." ScienceDaily. ScienceDaily, 22 December 2004. <www.sciencedaily.com/releases/2004/12/041219213620.htm>.
Mayo Clinic. (2004, December 22). First Blood Test To Diagnose Paralyzing, Blinding Disease. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2004/12/041219213620.htm
Mayo Clinic. "First Blood Test To Diagnose Paralyzing, Blinding Disease." ScienceDaily. www.sciencedaily.com/releases/2004/12/041219213620.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins